NCT04612920View on ClinicalTrials.gov

Towards Enhanced Recovery After Cesarean

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

December 12, 2020

Primary Completion Date

March 8, 2023

Study Completion Date

March 8, 2023

Conditions
Cesarean Section Complications
Interventions
DRUG

Ibuprofen, acetaminophen, oxycodone

The timing of medications is the intervention.

Trial Locations (1)

73104

University ofOklahoma Health Sciences Center, Oklahoma City

All Listed Sponsors
lead

University of Oklahoma

OTHER

NCT04612920 - Towards Enhanced Recovery After Cesarean | Biotech Hunter | Biotech Hunter